Answers are grounded in this paper and cite their sources.
Purpose: The BOne Strength (BOS) score is a computed tomography–based quantitative measure that can assist in the prediction of fracture risk in patients with femoral bone metastases. This study explored how the BOS score would impact (1) exercise prescription, (2) confidence in decision-making, and (3) the need to consult a physician before starting the exercise. Methods: Six realistic fictional case vignettes were drafted in pairs with comparable location and size of femur metastasis, Karnofsky Performance Score, and reason for exercise consultation. For each vignette, 10 Dutch physiotherapists were asked which exercises they would advise, their confidence levels on each decision, and whether consultation with a physician was needed before starting the training program. Participants were subsequently provided with high and low BOS scores per pair and answered the questions again. Data were analyzed descriptively. Results: Exercise prescription became more cautious when BOS scores indicated a high fracture risk and less conservative when indicating low fracture risk. Confidence in exercise choice tended to increase in the case of high BOS scores (low risk), but uncertainty remained in the case of low BOS scores (high risk). Finally, the need to consult a physician decreased when the BOS score was available. Conclusions: The BOS score is potentially a clinically relevant tool that could be used when prescribing exercises to patients with increased fracture risk due to femoral bone metastases.
No takes yet. Share an insight, caveat, or question.
Peters et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: